Viral genotypes and p53 expression in Epstein-Barr virus-associated primary malignant lymphomas of the intestines

Young Sik Kim, Jung Bun Kim, Yong Koo Kang, Eun Sook Nam, Seol Hee Park, Insun Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A small number (4% to 6%) of primary malignant lymphomas arising in the intestines express the EBV genome. However, in these tumors, the viral genotype and the role of tumor suppressor gene p53 have not been investigated. We sought to determine what genotype of EBV is frequently involved and whether the expression of p53 is related to these tumors. We used EBER-1 in situ hybridization and polymerase chain reactions (PCRs) for EBNA-1, EBNA-2A, and EBNA-2B to detect latent infection with EBV and to determine the genotype, respectively. In addition, we performed p53 PCR-SSCP (exons 5 through 9) and immunohistochemical analysis for p53. We found that EBV type B was present in 4 of 6 cases (67%); the genotype of the remaining cases could not be determined. The p53 PCR-SSCP indicated normal migration patterns in all malignant lymphomas, despite the fact that the tumor cells were strongly immunostained for p53 protein in 5 of the 6 cases. Thus, our study demonstrates that EBV-associated non-Hodgkin's lymphomas of the intestines in Korea are strongly related to the type B EBV and not to mutations of p53 gene. We suggest that EBV-associated intestinal lymphomas may arise through an interaction between the latent proteins of EBV and the wild-type p53 protein.

Original languageEnglish
Pages (from-to)1146-1152
Number of pages7
JournalHuman Pathology
Volume30
Issue number10
DOIs
Publication statusPublished - 1999 Oct 1

Fingerprint

Human Herpesvirus 4
Intestines
Lymphoma
Genotype
Single-Stranded Conformational Polymorphism
Polymerase Chain Reaction
Neoplasms
Proteins
Epstein-Barr Virus Infections
p53 Genes
Korea
Tumor Suppressor Genes
Non-Hodgkin's Lymphoma
In Situ Hybridization
Exons
Genome
Mutation

Keywords

  • Epstein-Barr virus
  • Genotype
  • Intestine
  • Malignant lymphoma
  • P53

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Viral genotypes and p53 expression in Epstein-Barr virus-associated primary malignant lymphomas of the intestines. / Kim, Young Sik; Kim, Jung Bun; Kang, Yong Koo; Nam, Eun Sook; Park, Seol Hee; Kim, Insun.

In: Human Pathology, Vol. 30, No. 10, 01.10.1999, p. 1146-1152.

Research output: Contribution to journalArticle

Kim, Young Sik ; Kim, Jung Bun ; Kang, Yong Koo ; Nam, Eun Sook ; Park, Seol Hee ; Kim, Insun. / Viral genotypes and p53 expression in Epstein-Barr virus-associated primary malignant lymphomas of the intestines. In: Human Pathology. 1999 ; Vol. 30, No. 10. pp. 1146-1152.
@article{bc9148e38d0548ad8a5f43b64221e023,
title = "Viral genotypes and p53 expression in Epstein-Barr virus-associated primary malignant lymphomas of the intestines",
abstract = "A small number (4{\%} to 6{\%}) of primary malignant lymphomas arising in the intestines express the EBV genome. However, in these tumors, the viral genotype and the role of tumor suppressor gene p53 have not been investigated. We sought to determine what genotype of EBV is frequently involved and whether the expression of p53 is related to these tumors. We used EBER-1 in situ hybridization and polymerase chain reactions (PCRs) for EBNA-1, EBNA-2A, and EBNA-2B to detect latent infection with EBV and to determine the genotype, respectively. In addition, we performed p53 PCR-SSCP (exons 5 through 9) and immunohistochemical analysis for p53. We found that EBV type B was present in 4 of 6 cases (67{\%}); the genotype of the remaining cases could not be determined. The p53 PCR-SSCP indicated normal migration patterns in all malignant lymphomas, despite the fact that the tumor cells were strongly immunostained for p53 protein in 5 of the 6 cases. Thus, our study demonstrates that EBV-associated non-Hodgkin's lymphomas of the intestines in Korea are strongly related to the type B EBV and not to mutations of p53 gene. We suggest that EBV-associated intestinal lymphomas may arise through an interaction between the latent proteins of EBV and the wild-type p53 protein.",
keywords = "Epstein-Barr virus, Genotype, Intestine, Malignant lymphoma, P53",
author = "Kim, {Young Sik} and Kim, {Jung Bun} and Kang, {Yong Koo} and Nam, {Eun Sook} and Park, {Seol Hee} and Insun Kim",
year = "1999",
month = "10",
day = "1",
doi = "10.1016/S0046-8177(99)90030-8",
language = "English",
volume = "30",
pages = "1146--1152",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - Viral genotypes and p53 expression in Epstein-Barr virus-associated primary malignant lymphomas of the intestines

AU - Kim, Young Sik

AU - Kim, Jung Bun

AU - Kang, Yong Koo

AU - Nam, Eun Sook

AU - Park, Seol Hee

AU - Kim, Insun

PY - 1999/10/1

Y1 - 1999/10/1

N2 - A small number (4% to 6%) of primary malignant lymphomas arising in the intestines express the EBV genome. However, in these tumors, the viral genotype and the role of tumor suppressor gene p53 have not been investigated. We sought to determine what genotype of EBV is frequently involved and whether the expression of p53 is related to these tumors. We used EBER-1 in situ hybridization and polymerase chain reactions (PCRs) for EBNA-1, EBNA-2A, and EBNA-2B to detect latent infection with EBV and to determine the genotype, respectively. In addition, we performed p53 PCR-SSCP (exons 5 through 9) and immunohistochemical analysis for p53. We found that EBV type B was present in 4 of 6 cases (67%); the genotype of the remaining cases could not be determined. The p53 PCR-SSCP indicated normal migration patterns in all malignant lymphomas, despite the fact that the tumor cells were strongly immunostained for p53 protein in 5 of the 6 cases. Thus, our study demonstrates that EBV-associated non-Hodgkin's lymphomas of the intestines in Korea are strongly related to the type B EBV and not to mutations of p53 gene. We suggest that EBV-associated intestinal lymphomas may arise through an interaction between the latent proteins of EBV and the wild-type p53 protein.

AB - A small number (4% to 6%) of primary malignant lymphomas arising in the intestines express the EBV genome. However, in these tumors, the viral genotype and the role of tumor suppressor gene p53 have not been investigated. We sought to determine what genotype of EBV is frequently involved and whether the expression of p53 is related to these tumors. We used EBER-1 in situ hybridization and polymerase chain reactions (PCRs) for EBNA-1, EBNA-2A, and EBNA-2B to detect latent infection with EBV and to determine the genotype, respectively. In addition, we performed p53 PCR-SSCP (exons 5 through 9) and immunohistochemical analysis for p53. We found that EBV type B was present in 4 of 6 cases (67%); the genotype of the remaining cases could not be determined. The p53 PCR-SSCP indicated normal migration patterns in all malignant lymphomas, despite the fact that the tumor cells were strongly immunostained for p53 protein in 5 of the 6 cases. Thus, our study demonstrates that EBV-associated non-Hodgkin's lymphomas of the intestines in Korea are strongly related to the type B EBV and not to mutations of p53 gene. We suggest that EBV-associated intestinal lymphomas may arise through an interaction between the latent proteins of EBV and the wild-type p53 protein.

KW - Epstein-Barr virus

KW - Genotype

KW - Intestine

KW - Malignant lymphoma

KW - P53

UR - http://www.scopus.com/inward/record.url?scp=13044313484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13044313484&partnerID=8YFLogxK

U2 - 10.1016/S0046-8177(99)90030-8

DO - 10.1016/S0046-8177(99)90030-8

M3 - Article

VL - 30

SP - 1146

EP - 1152

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 10

ER -